Search for a clinical trial
Other search option(s)
5 Result(s)
Recruiting trial
= ; Ongoing trial
=
; Terminated trial =
; Funded by an IRDiRC member =
; Member of a ERN =
National clinical trial(s)

CANADA
Ontario
TORONTO

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
St. Michael's Hospital
Keenan Research Centre

FRANCE
AUVERGNE-RHONE-ALPES
BRON
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
CHU de Lyon HCL - GH Est-Hôpital Femme Mère Enfant
Service de génétique

GERMANY
Bayern
REGENSBURG

Der Einfluss von Timolol Nasenspray auf Epistaxis bei Morbus Osler Patienten
Universitätsklinikum Regensburg
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde

ITALY
LOMBARDIA
PAVIA

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (Phase II)- IT
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III

NETHERLANDS
Gelderland
NIJMEGEN